US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
He told his Cabinet members at a meeting at the White House yesterday that the prices of prescription drugs in the US have gone through the roof.
Mr Trump did not mention any country, but his policy on prescription drugs, which was discussed during his Cabinet meeting could have implications for India.
This is because for instance, early this year India’s National Pharmaceutical Pricing Authority (NPAA) fixed the price of drug eluting stents at 450 US Dollars and bare metal stents at 110 US Dollars. NPAA has said that it intends to take similar measures for other costly medical devices.
